search tools

ABC NEWS AND TIME INC.’S PEOPLE ANNOUNCE NEW PRIMETIME SERIES: “PEOPLE’s LIST” (ABC Inc)

Edit Public Technologies 24 May 2016
(Source. ABC Inc). FEATURING A WEEKLY COUNTDOWN OF THE TOP PEOPLE WORTH WATCHING. HOSTED BY ACTOR JERRY O'CONNELL AND SUCHIN PAK. PREMIERES SATURDAY, JUNE 11 at 8 PM/ ET ON ABC ... Plus, the very latest in pop culture, style and trends ... About ABC News ... ABC News reaches a combined audience of well over 270 million people a month on television, on radio and online.* Over 1,000 affiliate stations broadcast ABC News Radio's global news coverage....

Noah Holdings Limited Announces Unaudited Financial Results for the First Quarter of 2016 (Noah Holdings Limited)

Edit Public Technologies 24 May 2016
(Source. Noah Holdings Limited). FIRST QUARTER 2016 FINANCIAL HIGHLIGHTS Net revenues in the first quarter of 2016 were RMB607.2 million (US$94.2 million), a 35.6% increase from the corresponding period in 2015. (RMB millions,. except percentages). Q1. 2015. Q1 2015. Segment %. Q1. 2016. Q1 2016. Segment %. YoY Change. Wealth management. 341.8. 76.3%. 463.6. 76.4%. 35.7%. Asset management. 96.8. 21.6%. 137.7. 22.7%. 42.3% ... 270,462,153 ... 270,462,153 ... (2,270,719)....

Vtesse avanza el ensayo clínico de fase 2b/3 de VTS-270 en la enfermedad de Niemann-Pick ...

Edit PR Newswire 23 May 2016
-Vtesse avanza el ensayo clínico de fase 2b/3 de VTS-270 en la enfermedad de Niemann-Pick de tipo C1 con selección de dosis para evaluación en la segunda y última parte del ensayo y la expansión a Europa Diez sitios clínicos reclutan ahora a pacientes en ... ....

Vtesse Advances Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease with Dose ...

Edit PR Newswire 23 May 2016
GAITHERSBURG, Md., May 23, 2016 /PRNewswire/ -- Vtesse, Inc. announced today that the dose-finding portion of the company's global, pivotal Phase 2b/3 clinical trial for its lead investigational product, VTS-270, for treatment of Niemann-Pick Type C1 Disease (NPC) is now complete, and a ... ....

BRIEF-Vtesse advances phase 2b/3 clinical trial of VTS-270

Edit Reuters 23 May 2016
* Advances Phase 2b/3 Clinical Trial Of VTS 270 in Niemann-Pick type c1 disease with dose selection for evaluation in second and final portion of trial and expansion into europe Source text for Eikon. (Bengaluru Newsroom. +1 646 223 8780) ....

Transylvania graduating 270 students Saturday (Transylvania University)

Edit Public Technologies 23 May 2016
(Source. Transylvania University). LEXINGTON, Ky.-On Saturday, May 28, Transylvania University will send 270 students into the world-Pioneers who are specially prepared to start their careers or continue their studies at graduate and professional schools. Lexington Mayor Jim Gray will give the commencement address to the students ... The class of 2016 will receive their degrees during the 9.30 a.m ... The rain location will be the Clive M....

Vtesse treibt klinische Phase-IIb/III-Studie zu VTS-270 bei Niemann-Pick-Erkrankung Typ C1 mit Dosisfindung für Evaluierung im ...

Edit PR Newswire 23 May 2016
Zehn klinische Zentren in den Vereinigten Staaten, dem Vereinigten Königreich, Spanien, Frankreich und Deutschland nun mit Patientenrekrutierung beschäftigt GAITHERSBURG, Maryland, 23. Mai 2016 /PRNewswire/ -- Vtesse, Inc. meldet heute, dass der Dosisfindungsteil seiner ... ....

Vtesse progresse lors de la phase 2b / 3 de l'essai clinique du VTS-270 contre ...

Edit PR Newswire 23 May 2016
Dix sites cliniques sont actuellement en train de recruter des patients aux États-Unis, au Royaume-Uni, en Espagne, en France et en Allemagne GAITHERSBURG, Maryland, 23 mai 2016 /PRNewswire/ -- Vtesse, Inc. a annoncé aujourd'hui que le volet de l'essai clinique en phase ... ....

Vtesse avanza alla fase 2b/3 nella prova clinica del VTS-270 per il morbo di Niemann-Pick ...

Edit PR Newswire 23 May 2016
Dieci cliniche stanno reclutando pazienti negli Stati Uniti, Regno Unito, Spagna, Francia e Germania GAITHERSBURG, Maryland, 23 maggio 2016 /PRNewswire/ -- Vtesse, Inc. ha annunciato oggi che la definizione del dosaggio nella fase 2b/3 della prova clinica globale e cruciale  ... ....

Gene Therapy Could Eliminate Infusion Treatments for Hemophilia (MEDIWARE Information Systems Inc)

Edit Public Technologies 23 May 2016
(Source. MEDIWARE Information Systems Inc) ... (4) ... On Mar ... announced that its investigational gene therapy, BMN 270, had been granted orphan drug designation by the U.S ... Currently, BioMarin is conducting a study to evaluate the safety and efficacy of BMN 270 in up to 12 patients with severe hemophilia A. According to the press release, BMN 270 is an 'AAV 5 factor VIII vector designed to restore factor VIII plasma concentrations….' (5)....

Box Office Top 20: 'Angry Birds' slingshots past 'Civil War'

Edit Springfield News-Sun 23 May 2016
In its first weekend in theaters, "The Angry Birds Movie" soared past "Captain America ... Newcomers "Neighbors 2. Sorority Rising" and "The Nice Guys," both R-rated comedies, fared less well ... The top 20 movies at U.S ... 1 ... 2. "Captain America ... 3 ... 4. "The Nice Guys," Warner Bros., $11,203,270, 2,865 locations, $3,910 average, $11,203,270, 1 week. 5 ... "The Man Who Knew Infinity," IFC Films, $495,694, 270 locations, $1,836 average, $1,627,021, 4 weeks....

Bluescope lifts its 2H earnings guidance

Edit Canberra Times 23 May 2016
Bluescope Steel expects second-half underlying earnings before interest and tax of about $270 million ... ....

Rescue efforts underway in flood-ravaged Sri Lanka

Edit Topix 23 May 2016
The Sri Lankan military is attempting to reach thousands of people stranded in their homes after the country was hit by the worst flooding in 25 years. "What we want to demonstrate with this visit is a significant upgrade in the relationship between the United States and Vietnam ... even as we have areas of difference" Editor-in-Chief. Nguyen Quang Thong 268-270 Nguyen Dinh Chieu St. , Distr ... ....
×
×
×
×